- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-BMA.4: 4 residues within 4Å:- Chain A: N.717, T.719, L.922, Q.926
 
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Q.926
 - Hydrogen bonds: A:Q.926
 
NAG-NAG-BMA.8: 2 residues within 4Å:- Chain B: N.280, N.282
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 3 residues within 4Å:- Chain C: N.343, L.368, S.371
 
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.371
 
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.16: 7 residues within 4Å:- Chain A: F.338, G.339, F.342, N.343, V.367, L.368, S.371
 
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain A: D.614, V.615, N.616, Q.644, R.646
 
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: H.655, N.657
 
Ligand excluded by PLIPNAG.19: 7 residues within 4Å:- Chain A: V.705, A.706, A.713, E.1072, K.1073, N.1074
 - Chain C: Q.895
 
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain A: N.1098, T.1100, H.1101, F.1103
 
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain B: T.307, N.603
 
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: V.656, N.657, N.658
 
Ligand excluded by PLIPNAG.23: 6 residues within 4Å:- Chain A: A.893, Q.895
 - Chain B: A.706, A.713, E.1072, N.1074
 
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain B: C.1082, G.1085, C.1126, N.1134
 
Ligand excluded by PLIPNAG.25: 7 residues within 4Å:- Chain C: N.122, A.123, T.124, N.125, V.127, M.153, V.171
 
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: T.108, I.233, N.234
 
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain C: P.330, N.331, Q.580
 
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain C: D.614, N.616, Q.644
 
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: D.796
 - Chain C: S.708, N.709, N.710
 
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Miersch, S. et al., Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations. J.Mol.Biol. (2021)
          


 - Release Date
 - 2021-02-03
 - Peptides
 - Spike glycoprotein: ABC
Fab 15033-7 light chain: DFH
Fab 15033-7 heavy chain: EGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
LF
MH
NE
HG
II
J 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Miersch, S. et al., Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations. J.Mol.Biol. (2021)
          


 - Release Date
 - 2021-02-03
 - Peptides
 - Spike glycoprotein: ABC
Fab 15033-7 light chain: DFH
Fab 15033-7 heavy chain: EGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
LF
MH
NE
HG
II
J